Multi-Organ Expression Profiling Uncovers a Gene Module in Coronary Artery Disease Involving Transendothelial Migration of Leukocytes and LIM Domain Binding 2: The Stockholm Atherosclerosis Gene Expression (STAGE) Study

Environmental exposures filtered through the genetic make-up of each individual alter the transcriptional repertoire in organs central to metabolic homeostasis, thereby affecting arterial lipid accumulation, inflammation, and the development of coronary artery disease (CAD). The primary aim of the Stockholm Atherosclerosis Gene Expression (STAGE) study was to determine whether there are functionally associated genes (rather than individual genes) important for CAD development. To this end, two-way clustering was used on 278 transcriptional profiles of liver, skeletal muscle, and visceral fat (n = 66/tissue) and atherosclerotic and unaffected arterial wall (n = 40/tissue) isolated from CAD patients during coronary artery bypass surgery. The first step, across all mRNA signals (n = 15,042/12,621 RefSeqs/genes) in each tissue, resulted in a total of 60 tissue clusters (n = 3958 genes). In the second step (performed within tissue clusters), one atherosclerotic lesion (n = 49/48) and one visceral fat (n = 59) cluster segregated the patients into two groups that differed in the extent of coronary stenosis (P = 0.008 and P = 0.00015). The associations of these clusters with coronary atherosclerosis were validated by analyzing carotid atherosclerosis expression profiles. Remarkably, in one cluster (n = 55/54) relating to carotid stenosis (P = 0.04), 27 genes in the two clusters relating to coronary stenosis were confirmed (n = 16/17, P<10−27and−30). Genes in the transendothelial migration of leukocytes (TEML) pathway were overrepresented in all three clusters, referred to as the atherosclerosis module (A-module). In a second validation step, using three independent cohorts, the A-module was found to be genetically enriched with CAD risk by 1.8-fold (P<0.004). The transcription co-factor LIM domain binding 2 (LDB2) was identified as a potential high-hierarchy regulator of the A-module, a notion supported by subnetwork analysis, by cellular and lesion expression of LDB2, and by the expression of 13 TEML genes in Ldb2–deficient arterial wall. Thus, the A-module appears to be important for atherosclerosis development and, together with LDB2, merits further attention in CAD research.

[1]  R. Frye,et al.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. , 1975, Circulation.

[2]  F. H. Sims,et al.  A comparison of coronary and internal mammary arteries and implications of the results in the etiology of arteriosclerosis. , 1983, American heart journal.

[3]  J. Saltiel,et al.  Clinical and angiographic correlates and prognostic significance of the coronary extent score. , 1988, The American journal of cardiology.

[4]  T. Craven,et al.  Central adipose distribution is related to coronary atherosclerosis. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[5]  F. Alt,et al.  LH-2: a LIM/homeodomain gene expressed in developing lymphocytes and neural cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  N B Schiller,et al.  Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease. , 1993, Journal of the American College of Cardiology.

[7]  J. Palmblad,et al.  Signal transduction mechanisms for leukotriene B4 induced hyperadhesiveness of endothelial cells for neutrophils. , 1994, Journal of immunology.

[8]  J. J. Breen,et al.  Interactions of the LIM-domain-binding factor Ldbl with LIM homeodomain proteins , 1996, Nature.

[9]  H. Heng,et al.  Identification of a human LIM-Hox gene, hLH-2, aberrantly expressed in chronic myelogenous leukaemia and located on 9q33-34.1. , 1996, Oncogene.

[10]  Blatt,et al.  Superparamagnetic clustering of data. , 1998, Physical review letters.

[11]  T Gustavsson,et al.  A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness. , 1997, Stroke.

[12]  S. Potter,et al.  Multistep control of pituitary organogenesis. , 1997, Science.

[13]  L. Jurata,et al.  Functional analysis of the nuclear LIM domain interactor NLI , 1997, Molecular and cellular biology.

[14]  T. Rabbitts,et al.  The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Stengel,et al.  Inhibition of LPL expression in human monocyte-derived macrophages is dependent on LDL oxidation state: a key role for lysophosphatidylcholine. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[16]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[18]  T. Rabbitts,et al.  The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Getz,et al.  Coupled two-way clustering analysis of gene microarray data. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  T. Mak,et al.  Brca1 required for T cell lineage development but not TCR loci rearrangement , 2000, Nature Immunology.

[21]  R. Flavell,et al.  Conditional Vascular Cell Adhesion Molecule 1 Deletion in Mice , 2001, The Journal of experimental medicine.

[22]  M. Fujimiya,et al.  Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin. , 2002, Diabetes.

[23]  Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators , 2003, Circulation.

[24]  E. Kubista,et al.  Defect of tumour necrosis factor-alpha (TNF-alpha) production and TNF-alpha-induced ICAM-1-expression in BRCA1 mutations carriers. , 2003, Breast cancer research and treatment.

[25]  K. Imai,et al.  The LIM-only protein, LMO4, and the LIM domain-binding protein, LDB1, expression in squamous cell carcinomas of the oral cavity , 2003, British Journal of Cancer.

[26]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[27]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[28]  S. Young,et al.  Eliminating Atherogenesis in Mice by Switching Off Hepatic Lipoprotein Secretion , 2003, Circulation.

[29]  Igor V. Tetko,et al.  Super paramagnetic clustering of protein sequences , 2005, BMC Bioinformatics.

[30]  Michiel L. Bots,et al.  Intima Media Thickness as a Surrogate Marker for Generalised Atherosclerosis , 2002, Cardiovascular Drugs and Therapy.

[31]  L. Lanting,et al.  Interaction of Monocytes With Vascular Smooth Muscle Cells Regulates Monocyte Survival and Differentiation Through Distinct Pathways , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[32]  D. Tanné,et al.  Spiral computed tomography evidence of close correlation between coronary and thoracic aorta calcifications. , 2004, Atherosclerosis.

[33]  L. Lanting,et al.  Growth factors induce monocyte binding to vascular smooth muscle cells: implications for monocyte retention in atherosclerosis. , 2004, American journal of physiology. Cell physiology.

[34]  P. T. Larsson,et al.  Carotid Atherosclerosis is Correlated with Extent and Severity of Coronary Artery Disease Evaluated by Myocardial Perfusion Scintigraphy , 2004, Angiology.

[35]  E. Kubista,et al.  Defect of Tumour Necrosis Factor-α (TNF-α) Production and TNF-α-induced ICAM-1 – Expression in BRCA1 Mutations Carriers , 2003, Breast Cancer Research and Treatment.

[36]  Z. Szallasi,et al.  Sequence-matched probes produce increased cross-platform consistency and more reproducible biological results in microarray-based gene expression measurements. , 2004, Nucleic acids research.

[37]  G. Ginsburg,et al.  Prospects for personalized cardiovascular medicine: the impact of genomics. , 2005, Journal of the American College of Cardiology.

[38]  S. Friend,et al.  Embracing Complexity, Inching Closer to Reality , 2005, Science's STKE.

[39]  Christian von Mering,et al.  STRING: known and predicted protein–protein associations, integrated and transferred across organisms , 2004, Nucleic Acids Res..

[40]  P. Scherer,et al.  Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.

[41]  F. Mach,et al.  Leukocyte recruitment in atherosclerosis: Potential targets for therapeutic approaches? , 2006, Cellular and Molecular Life Sciences CMLS.

[42]  Elisabetta Dejana,et al.  Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[43]  J. Eeckhoute,et al.  Hepatocyte nuclear factor 4 alpha ligand binding and F domains mediate interaction and transcriptional synergy with the pancreatic islet LIM HD transcription factor Isl1. , 2006, Journal of molecular biology.

[44]  Aldons J. Lusis,et al.  A thematic review series: systems biology approaches to metabolic and cardiovascular disorders , 2006, Journal of Lipid Research.

[45]  Alexander E. Kel,et al.  TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes , 2005, Nucleic Acids Res..

[46]  C. Söderberg-Nauclér,et al.  Human Cytomegalovirus Downregulates Expression of Receptors for Platelet-Derived Growth Factor by Smooth Muscle Cells , 2007, Journal of Virology.

[47]  P. Quax,et al.  Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[48]  J. Tegnér,et al.  Perturbations to uncover gene networks. , 2007, Trends in genetics : TIG.

[49]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[50]  J. Tegnér,et al.  Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Multi-organ whole-genome measurements and reverse engineering to uncover gene networks underlying complex traits Published, JLR Papers in Press, December 1, 2006. , 2007, Journal of Lipid Research.

[51]  David Hinkley,et al.  Bootstrap Methods: Another Look at the Jackknife , 2008 .

[52]  G. Gibson.  The environmental contribution to gene expression profiles , 2008, Nature Reviews Genetics.

[53]  PECAM-1 is a critical mediator of atherosclerosis , 2008, Disease Models & Mechanisms.

[54]  J. Bradley,et al.  TNF‐mediated inflammatory disease , 2008, The Journal of pathology.

[55]  E. Birney,et al.  Pfam: the protein families database , 2013, Nucleic Acids Res..

[56]  John D. Storey,et al.  Mapping the Genetic Architecture of Gene Expression in Human Liver , 2008, PLoS biology.

[57]  J. Tegnér,et al.  Transcriptional Profiling Uncovers a Network of Cholesterol-Responsive Atherosclerosis Target Genes , 2008, PLoS genetics.

[58]  H. Westphal,et al.  The Ldb1 and Ldb2 transcriptional cofactors interact with the Ste20-like kinase SLK and regulate cell migration. , 2009, Molecular biology of the cell.

[59]  T. V. van Berkel,et al.  Vaccination against TIE2 reduces atherosclerosis. , 2009, Atherosclerosis.

[60]  L. Holm,et al.  The Pfam protein families database , 2005, Nucleic Acids Res..